Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Slides:



Advertisements
Similar presentations
Elizabeth A. David, MD, David T
Advertisements

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database 
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Chun Chieh Lin, PhD, MBA, Matthew P
Joshua E. Rosen, BASc, Hari B
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Trevor Williams, MD, MPH, Brian C
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Heart Transplantation for the Failing Fontan
Dhaval Chauhan, MD, Alexis K
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 
Castigliano M. Bhamidipati, DO, MS, George J
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Operative Results and Outcomes in Children With Shone's Anomaly
Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy  Jessica M. Moore, BS, Craig M. Hooker, PhD,
Andrew C. Chang, MD, Julia S. Lee, MS, Konrad T
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y
Trevor Williams, MD, MPH, Brian C
Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients  Giovanni Filardo, PhD, MPH,
Surgical Resection of Rare Esophageal Cancers
Lung Cancer Surgery in Patients With Liver Cirrhosis
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies  Bahaaldin Alsoufi, MD, Scott Gillespie, MS, Dennis Kim,
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Michael Lanuti, MD, Pierre E
Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis  Michael Mazzeffi, MD, MPH, John.
Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer
Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A
Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy  Pamela Samson, MD, MPHS,
Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M
Adriaan W. Schneider, MD, Nico A. Blom, MD, PhD, Eline F
Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices  Shinichi Fukuhara, MD,
Editorial Board, January 2010
Understanding Mortality as a Quality Indicator After Esophagectomy
William M. Whited, MD, Paul Henley, BS, Erin M
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
A. Thomas Pezzella, MD, Sari D
Pilot Study to Integrate Patient Reported Outcomes After Lung Cancer Operations Into The Society of Thoracic Surgeons Database  Onkar V. Khullar, MD,
Specialty Training and Mortality After Esophageal Cancer Resection
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival  Shuli Silberman, MD, Daniel Bitran, MD, Daniel.
Rachel L. Medbery, MD, Sebastian D. Perez, MSPH, Seth D
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging  Jennifer.
Chest Wall Reconstruction Using Biomaterials
Onkar V. Khullar, MD, Felix G
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Yangfeng Tang, MD, Zilin Liao, MD, Lin Han, MD, Zhiyun Xu, MD 
Thoracoscopy Without Lung Isolation Utilizing Single Lumen Endotracheal Tube Intubation and Carbon Dioxide Insufflation  Manu S. Sancheti, MD, Brendan.
Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement  Heinrich Koertke, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy  Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Risk of Valve-Related Events After Aortic Valve Repair
Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M
Presentation transcript:

Hospital Readmission Is Associated With Poor Survival After Esophagectomy for Esophageal Cancer  Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D. Force, MD, Renjian Jiang, MPH, Allan Pickens, MD, David Howard, PhD, Kevin Ward, PhD, MPH, Theresa Gillespie, PhD  The Annals of Thoracic Surgery  Volume 99, Issue 1, Pages 292-297 (January 2015) DOI: 10.1016/j.athoracsur.2014.07.052 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Proportion of readmissions within 30 days of discharge, stratified by day after discharge. (Curve indicates normal [mu = 12.226; sigma = 8.2483].) The Annals of Thoracic Surgery 2015 99, 292-297DOI: (10.1016/j.athoracsur.2014.07.052) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier overall survival curves for patients readmitted to the hospital within 30 days (red line) after hospital readmission after esophagectomy, compared with patients not readmitted (blue line) to the hospital during that period. A significant difference was noted between the survival curve (p = 0.0015, log rank test). (Hatch marks = censored.) The Annals of Thoracic Surgery 2015 99, 292-297DOI: (10.1016/j.athoracsur.2014.07.052) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions